Anand V Kulkarni's Avatar

Anand V Kulkarni

@anandvkulkarni.bsky.social

Hepatologist at AIG Hospitals, Hyderabad, India. Interests in ALD, ACLF & HCC

458 Followers  |  323 Following  |  17 Posts  |  Joined: 12.11.2024  |  2.0415

Latest posts by anandvkulkarni.bsky.social on Bluesky

Preview
Ascites in patients with end-stage renal disease:... : Hepatology Communications d. However, patients with end-stage renal disease (ESRD) may also present with ascites even in the absence of cirrhosis. The literature on the management of patients with ESRD with ascites with or wit...

With rising burden of metabolic diseases we are struggling with management of ascites in CKD. Here we try to answer them & provide an overview of approach to ascites in ESRD. @ebtapper.bsky.social @akashroyy.bsky.social

journals.lww.com/hepcomm/full...

03.04.2025 17:17 β€” πŸ‘ 5    πŸ” 3    πŸ’¬ 0    πŸ“Œ 1
Preview
Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial Participation in screening was higher among individuals invited to faecal immunochemical test screening than colonoscopy screening. On the basis of participation observed in this study, a faecal immun...

Patients were randomized to FIT vs colonoscopy for colon cancer screening. Participation in any form of screening was 31.8% in the colonoscopy group and 39.9% in the FIT group. 10-year colon cancer mortality risk was 0.22% in colonoscopy arm and 0.24% in FIT arm.
www.thelancet.com/journals/lan...

30.03.2025 01:06 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Thank you πŸ™πŸ»

29.03.2025 00:54 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Prevalence of metabolic dysfunction-associated fatty liver disease among information technology employees in India - PubMed The Information Technology (IT) sector is a leading industry that fuels India's economic growth. However, the work culture in this sector often promotes sedentary lifestyle, inadequate physical activi...

A survey based study from AIG team and UoH on IT individuals who agreed to undergo tests
pubmed.ncbi.nlm.nih.gov/40128210/
>80% have fat in liver
20% have elevated liver enzymes
2% have fibrosis (advanced disease)
Fatty liver is curable with exercise (150 min/week) and healthy diet #Liversky

28.03.2025 00:49 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0

Yes . No doubt 😞

14.03.2025 02:00 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Thank you Hanna. In our settings most patients don’t agree for LT at all & we see at least 4 new AH patients per day and hardly one may fit for steroids therapy up front. We usually stabilize and then start steroids. Under supervision they do pretty well.

14.03.2025 00:58 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

Phenomenal

13.03.2025 19:48 β€” πŸ‘ 4    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Thank you Rohit

13.03.2025 17:24 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

@rohitmehtani.bsky.social @hughthomas00.bsky.social @robbrierley.bsky.social @spaulliver.bsky.social @andrewmmoon.bsky.social @heykatray.bsky.social @anaostojic.bsky.social @vivekgtank.bsky.social @wongyujun.bsky.social @jonathanstinemd.bsky.social @kbibbinsdomingo.bsky.social

13.03.2025 17:17 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Preview
Infections in Standard or Tapered Dose of Prednisolone for... : Official journal of the American College of Gastroenterology | ACG mary objective was to assess the incidence of infection by day 90. The key secondary objectives were the incidence of mortality, acute kidney injury (AKI), readmissions rate and adverse events. Metho...

After five decades, steroid dosing in AAH is revisited: Tapered prednisolone proves superior in reducing infections.
#STASH trial @jasmohanbajaj.bsky.social @juanpabloarab.bsky.social @ebtapper.bsky.social @tonybreu.bsky.social
@blaneymd.medsky.social
journals.lww.com/ajg/abstract... #liversky

13.03.2025 17:12 β€” πŸ‘ 12    πŸ” 7    πŸ’¬ 2    πŸ“Œ 1
Preview
Acute-on-chronic liver failure (ACLF): the β€˜Kyoto Consensus’—steps from Asia - Hepatology International Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus...

The latest ACLF guidelines on harmonization of definition - steps from Asia. Joined by all the experts across the globe. Exhaustive recent updates and future directions.
@robbrierley.bsky.social @stevenbollipo.bsky.social @liveraim.bsky.social
link.springer.com/article/10.1...

22.02.2025 09:28 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Tips cannot prevent cirrhosis progression. Patients are okay without bleed for 3-4 years- then continue to develop complications. Having said that yes,I strongly recommend TIPS for bleeders but not for refractory ascites.Very poor outcomes! The QoL post TIPS for ascites is significantly affected.

05.01.2025 11:50 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

πŸ“’Thrilled to share our latest review article. Greatful to Prof. Rakhi Maiwall. We explore challenges of managing septic shock in cirrhosis and advocate for personalized approaches
pubmed.ncbi.nlm.nih.gov/39744868/

#liversky #Medsky #GIsky

@anandvkulkarni.bsky.social

04.01.2025 02:12 β€” πŸ‘ 3    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0

There are *some* people whom steroids help

There is still value in trials, pragmatic trials, that refine inclusion criteria, dose, duration, and stopping rules

@anandvkulkarni.bsky.social
@juanpabloarab.bsky.social
@blaneymd.bsky.social

12.12.2024 13:11 β€” πŸ‘ 11    πŸ” 3    πŸ’¬ 2    πŸ“Œ 0

Absolutely sir. Patient selection is the key!

12.12.2024 17:36 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Congrats to inspiring investigators @anandvkulkarni.bsky.social @juanpabloarab.bsky.social and team, for late breaking abstract about rapid taper of steroids in AAH at #TLM24
‡️ infections, hospitalizations with rapid taper
πŸ’« changing practice in management of AAH
#LiverSky #AASLD

19.11.2024 20:19 β€” πŸ‘ 10    πŸ” 2    πŸ’¬ 1    πŸ“Œ 0

Hey Vinay, thank you. Nice meeting you.
Best

19.11.2024 21:41 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image Post image

Dose tapering reduced incidence of infection and use of antibiotics. No difference noted in survival #TLM24 #LiverSky

18.11.2024 23:23 β€” πŸ‘ 8    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

Anand Kulkarni presents data from the STASH trial of dose tapering vs fixed dose corticosteroids in patients with severe alcohol-associated hepatitis #TLM24 #LiverSky

18.11.2024 23:18 β€” πŸ‘ 5    πŸ” 4    πŸ’¬ 2    πŸ“Œ 0

No difference in mortality though.

19.11.2024 15:59 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

This study by challenges dogma

@anandvkulkarni.bsky.social gave a tapering dose of prednisone for alcohol hepatitis instead of 40mg for 28 days

And it paid off with fewer infections

@tonybreu.bsky.social

18.11.2024 23:42 β€” πŸ‘ 51    πŸ” 11    πŸ’¬ 4    πŸ“Œ 1
Post image Post image Post image Post image

Leon Schiff SOA lecture by @jasmohanbajaj.bsky.social on HE @ebtapper.bsky.social #TLM24

18.11.2024 16:37 β€” πŸ‘ 5    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Drugs for Mash cirrhosis by Prof Mazen Noureddin #TLM24

15.11.2024 17:03 β€” πŸ‘ 8    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Post image

Join to learn and discuss about Management of ACLF #Aasld #liversky

13.11.2024 03:45 β€” πŸ‘ 6    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

I’ll be moderating a webinar tomorrow (Nov 13th) in conjunction with The Hepatitis Fund, as part of London Global Cancer Week 2024.

Join us to learn more on how liver cancer can be prevented via the elimination of viral hepatitis!

Register: us06web.zoom.us/webinar/regi...

#GastroSky #LiverSky

12.11.2024 16:03 β€” πŸ‘ 8    πŸ” 2    πŸ’¬ 0    πŸ“Œ 1

Please put your info in your profile! It really helps decide who to follow

12.11.2024 15:47 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Dr Tapper cares not only for patients but for liver and GI docs. Thank you so much for this- Very useful #liversky @ebtapper.bsky.social

12.11.2024 02:23 β€” πŸ‘ 5    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

So fun seeing all of my #livertwitter (πŸͺ¦β”) friends now on #LiverSky (and IRL #TLM24)

12.11.2024 01:42 β€” πŸ‘ 14    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0

@anandvkulkarni is following 20 prominent accounts